The discussion contained in this Annual Report
on Form 10-K contains “forward-looking statements” within the meaning of Section 27A of the United States Securities Act of
1933, as amended, and Section 21E of the United States Securities Exchange Act of 1934, as amended. Any statements about our expectations,
beliefs, plans, objectives, assumptions or future events or performance are not historical facts and may be forward-looking. These statements
are often, but not always, made through the use of words or phrases like “anticipate,” “estimate,” “plans,”
“projects,” “continuing,” “ongoing,” “target,” “expects,” “management
believes,” “we believe,” “we intend,” “we may,” “we will,” “we should,”
“we seek,” “we plan,” the negative of those terms, and similar words or phrases. We base these forward-looking
statements on our expectations, assumptions, estimates and projections about our business and the industry in which we operate as of the
date of this Form 10-K. These forward-looking statements are subject to a number of risks and uncertainties that cannot be predicted,
quantified or controlled and that could cause actual results to differ materially from those set forth in, contemplated by, or underlying
the forward-looking statements. Statements in this Form 10-K describe factors, among others, that could contribute to or cause these
differences. Actual results may vary materially from those anticipated, estimated, projected or expected should one or more of these risks
or uncertainties materialize, or should underlying assumptions prove incorrect. Because the factors discussed in this Form 10-K could
cause actual results or outcomes to differ materially from those expressed in any forward-looking statement made by us or on our behalf,
you should not place undue reliance on any such forward-looking statement. New factors emerge from time to time, and it is not possible
for us to predict which will arise. In addition, we cannot assess the impact of each factor on our business or the extent to which any
factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statement.
Except as required by law, we undertake no obligation to publicly revise our forward-looking statements to reflect events or circumstances
that arise after the date of this Form 10-K.
Corporate Structure
Organic Agricultural Company Limited (“Organic
Agricultural”, the “Company”, “we” or “us”) was incorporated in the State of Nevada on April
17, 2018. Our website address is www.oacl.top. Our website and the information contained on, or that can be accessed through, the website
is not deemed to be incorporated by reference in, and is not considered part of, this Report.
The Company carries on business through its subsidiaries
with headquarters in Harbin and Xiamen of China. When initially organized, the Company’s operating subsidiaries consisted of 51%
owned Baoqing County Lvxin Paddy Rice Plant Specialized Cooperative (“Lvxin”), which grew and distributed unmilled selenium-enriched
rice (“paddy”), and Heilongjiang Yuxinqi Agricultural Technology Development Company Limited (“Yuxinqi”), which
marketed agricultural products. On November 5, 2020, Tianci Wanguan (Xiamen) Digital Technology Company Limited, a 51% owned operating
subsidiary, was incorporated. In April 2020, the Company sold its 51% interest in Lvxin to the representative of the minority shareholders
in Lvxin. The divestment of Lvxin will enable the Company to focus on its other business: processing and marketing food products.
With the sale of Lvxin, the Company’s remaining
subsidiaries are:
Organic Agricultural (Samoa) Co., Ltd.
(“Organic Agricultural Samoa”), a wholly owned limited company registered in Samoa on December 15, 2017. Organic Agricultural
Samoa owns all of the outstanding shares of capital stock of Organic Agricultural Company Limited (Hong Kong).
Organic Agricultural Company Limited (Hong
Kong) (“Organic Agricultural HK”), which was established on December 6, 2017 under the laws of Hong Kong. Organic Agricultural
HK wholly owns all of the registered equity of Heilongjiang Tianci Liangtian Agricultural Technology Development Company Limited and 51%
of the registered equity of Tianci Wanguan (Xiamen) Digital Technology Company Limited.
Heilongjiang Tianci Liangtian Agricultural
Technology Development Company Limited. (“Tianci Liangtian”), a wholly owned limited company registered in Heilongjiang,
China on November 2, 2017. Tianci Liangtian owns all of the registered equity of Yuxinqi.
Heilongjiang Yuxinqi Agricultural Technology
Development Company Limited (“Yuxinqi”), which was incorporated in Heilongjiang, China on February 5, 2018. Tianci Liangtian
organized Yuxinqi to function as a marketing company, selling paddy and other crops to customers in the PRC. Yuxinqi shares offices in
Harbin with Tianci Liangtian. Yuxinqi was initially engaged in marketing exclusively for Lvxin, and recorded its first sales in the quarter
ended December 31, 2018. As our operations grow, Yuxinqi will undertake a broader range of marketing activities, both for paddy and for
other food products.
Tianci Wanguan (Xiamen) Digital Technology
Company Limited (“Tianci Wanguan”), a company incorporated in Xiamen, China on November 5, 2020, is 51% owned by Organic
Agricultural HK. In connection with the growing use of blockchain technology in sales, Tianci Wanguan was created to provide software
development to customers. At this stage, Tianci Wanguan provides software development services to customers through third-party software
development companies.
Our present corporate structure is as follows:
Our Business
Our subsidiary, Yuxinqi, was organized in February
2018. To date, Yuxinqi has devoted its efforts to the marketing and distribution of selenium-enriched agricultural products, primarily
paddy rice. Going forward, Yuxinqi intends to continue its focus on the marketing and sale of selenium-enriched products, while enlarging
its offerings to include a variety of crop foods as well as processed foods.
The purpose of Tianci Wanguan is to promote the
use of blockchain technology in sales, specifically the development of tracing systems for agricultural products, the development of a
blockchain-based shopping mall for agricultural products, and related improvements to the agricultural industry. Tianci Wanguan was organized
in November 2020 based on the Cooperation Agreement with Unbounded IOT Block Chain Limited (“Unbounded”). Tianci Wanguan’s
focus is on providing software development for other customers.
Software Development
In connection with the growing use of blockchain
technology in sales, specifically the development of tracing systems for agricultural products, Tianci Wanguan is developing a blockchain-based
shopping mall for agricultural products, and related technology for the agricultural industry. In addition, Tianci Wanguan will provide
software development to other customers. At this stage, Tianci Wanguan provides software development services to customers through third-party
software development companies.
Selenium-Enriched Products
Selenium is one of the “essential”
nutrients for humans, meaning that our bodies cannot produce it, and so we have to get it from our diet. Selenium deficiency can cause
health problems including Keshan’s disease, a form of cardiomyopathy. The World Health Organization has found that between 50 and
250 micrograms of selenium constitute a healthy daily intake.
Scientists now know selenium is necessary in the
body’s production of selenoproteins, a family of proteins that contain selenium in the form of an amino acid. So far, 25 different
selenoproteins in the body have been isolated, but only half of their functions have been identified. Selenium is one of several nutrients
known to have antioxidant properties, meaning selenium plays a part in chemical reactions that stop free radicals from damaging cells
and DNA. Human and animal research has found selenoproteins are involved in embryo development, thyroid hormone metabolism, antioxidant
defense, sperm production, muscle function and the immune system’s response to vaccinations. Antioxidant supplements, including
selenium, are often touted to help prevent heart disease, cancer and vision loss.
According to the Chinese Selenium Supplements
Association, selenium is purported to help people with asthma, and reduce the risk of rheumatoid arthritis and cardiovascular disease.
Selenium levels drop with age, so some have claimed selenium can slow the aging process, cognitive decline and dementia. Low selenium
levels are also implicated in depression, male infertility, weak immune systems and thyroid problems.
Plants grown in soil containing selenium convert
it into a form that is usable to humans and animals. Soil around the world varies in its selenium concentration. The higher the concentration
of selenium in soil, the higher the concentration of selenium is in crops. Soil in Nebraska, South and North Dakota, for example, is especially
rich in selenium, and people living in these areas typically have the highest dietary intake of selenium in the United States. On
the other hand, seventy-two percent (72%) of the land in China is selenium-poor.
Because rice is a staple food in China, selenium-enriched
rice obtained by bioenrichment to increase the selenium content of rice was determined to be a good selenium source for the population
in selenium-deficient regions.
All our products come from the Sanjiang Plain.
The Sanjiang Plain is noteworthy for, among other things, the relatively high content of selenium in its soil. By focusing on the marketing
and distribution of selenium-enhanced rice, the Company hopes to develop a sustainable position in the Chinese rice market.
Operating Licenses
Our products are subject to regulation by governmental
agencies in the PRC and Heilongjiang Province. Business and company registrations, along with the products, are certified on a regular
basis and must be in compliance with the laws and regulations of the PRC and provincial and local governments and industry agencies, which
are controlled and monitored through the issuance of licenses. Our licenses include:
| ● | Tianci
Liangtian and Yuxinqi operating licenses enable us to undertake agricultural technology development services, primary processing of agricultural
products, grain and legume cultivation, and agricultural product sales. (Legally approved projects can be launched after approval by
the relevant departments). The registration numbers are 91230100MA1ATNP757 and 91230109MA1AYU4P51, respectively; and they are valid from
November 2, 2017 and February 5, 2018, respectively, with no expiration date. |
Competition
Currently, the distribution of selenium-enriched
agricultural products in China is the province of small and medium-sized enterprises, with no dominant participant in the market. The
diversity of the market is primarily a function of the relatively brief period that the inclusion of selenium-enriched food stuffs in
the Chinese diet has been popular. As the practice becomes more well-established, the emergence of market leaders will be likely.
We are a small company. However, with our recent
focus on distribution of selenium-enriched products, we are entering a growing market. We believe that we will be able to compete effectively
in this market because we have the advantage of product specificity, which should enable our brand to become identified as a source for
selenium-enriched products.
Suppliers
Over the years of operations, we have developed
a solid and reliable image and reputation with suppliers. We have established supplier relationships with several local companies.
On April 24, 2020 the subsidiary of Heilongjiang
Tianci Liangtian Agricultural Technology Development Co., Ltd entered into an Equity Transfer Agreement providing for the transfer to
Lou Zhengui of Tianci’s 51% interest in the equity of Baoqing County Lvxin Paddy Rice Plant Specialized Cooperative. The Agreement
transferred the equity to Lou Zhengui as of April 30, 2020. The contract also provides that Lvxin will continue to sell paddy rice to
Yixinqi, and the Company has the right of priority under an agreed upon price.
Marketing
We believe that the importance of selenium to
human health and the fact of selenium deficiency in large parts of China create a vast market potential for development. Selenium has
been studied extensively in China. These efforts have resulted in confirming that selenium is an important element for human health and
that there are areas within China that are significantly deficient in the soil and water. In the past decade, Chinese government policy
has helped to enhance the importance of selenium and the potential of the selenium market.
The Company offers value-added products, both
products based on rice and products based on other food stuffs, such as organic red beans and millet.
Insurance
We do not maintain fire, theft, product liability
or other insurance of any kind. We bear the economic risk with respect to loss of or damage or destruction to our property and to the
interruption of our business as well as liability to third parties for damage or destruction to them or their property that may be caused
by our personnel or products.
Income Taxes
United States
The company is subject to a tax rate of 21% in
the United States of America.
Samoa
Organic Agricultural (Samoa) Co., Ltd was incorporated
in Samoa and, under the current laws of Samoa, is not subject to income tax.
China
Tianci Liantian, Yuxinqi and Tianci Wanguan are
subject to a 25% standard enterprise income tax in the PRC.
Employees
As of March 31, 2022, we had 32 employees.
None of our employees are represented by a labor union or similar collective bargaining organization.
An investment in our common stock involves a high
degree of risk. You should carefully consider the following risk factors and other information in this 10K before deciding to invest in
our Company. If any of the following risks actually occur, our business, financial condition and results of operations could be seriously
harmed. As a result, the trading price of our common stock could decline and you could lose all or part of your investment.
Risks Related to Our Business
Changes in relations between the United States
and China and/or regulations may adversely impact our business, our operating results, our ability to raise capital and the market price
of our shares.
The U.S. government, including the SEC, has made
statements and taken actions that led to changes in United States relations with China, and will impact companies with connections to
the United States or China. Actions by the U.S. government included imposing several rounds of tariffs affecting certain products manufactured
in China and imposing certain sanctions and restrictions in relation to China. Actions by the SEC included issuing statements indicating
its intent to make enhanced review of companies with significant China-based operations. It is unknown whether and to what extent new
legislation, executive orders, tariffs, laws or regulations will be adopted, or the effect that any such actions would have on companies
with significant connections to the U.S. or to China, our industry or on us. Any unfavorable government policies on cross-border relations,
including increased scrutiny of companies with significant China-based operations, capital controls or tariffs, may affect our ability
to raise capital and the market price of our shares.
Furthermore, the SEC has issued statements primarily
focused on companies with significant China-based operations, such as us. For example, on July 30, 2021, Gary Gensler, Chairman of the
SEC, issued a Statement on Investor Protection Related to Recent Developments in China, in which Chairman Gensler stated that he has asked
the SEC staff to engage in targeted additional reviews of filings for companies with significant China-based operations. The statement
also addressed risks inherent in companies with a Variable Interest Entity, or a VIE structure. We do not have a VIE structure and are
not in an industry that is subject to foreign ownership limitations by China. Further, we believe that we have robust disclosures relating
to our operations in China, including the relevant risks noted in Chairman Gensler’s statement. However, it is possible that the
Company’s periodic reports and other filings with the SEC may be subject to enhanced review by the SEC and this additional scrutiny
could affect our ability to effectively raise capital in the United States.
In response to the SEC’s July 30 statement,
the China Securities Regulatory Commission (CSRC) announced on August 1, 2021 that “it is our belief that Chinese and U.S. regulators
shall continue to enhance communication with the principle of mutual respect and cooperation, and properly address the issues related
to the supervision of China-based companies listed in the U.S. so as to form stable policy expectations and create a benign rules framework
for the market.” While the CSRC will continue to collaborate “closely with different stakeholders including investors, companies,
and relevant authorities to further promote transparency and certainty of policies and implementing measures,” CSRC emphasized that
it “has always been open to companies’ choices to list their securities on international or domestic markets in compliance
with relevant laws and regulations.”
If any new legislation, executive orders, tariffs,
laws and/or regulations are implemented, if existing trade agreements are renegotiated or if the U.S. or Chinese governments take retaliatory
actions due to the recent U.S.-China tensions, such changes could have an adverse effect on our business, financial condition and results
of operations, our ability to raise capital and the market price of our shares.
Our independent registered public accounting
firm has expressed substantial doubt about our ability to continue as a going concern.
The Company continues to generate operating losses and has not completed
its efforts to establish a stabilized source of revenue sufficient to cover its operating costs over an extended period of time. These
factors, among others, caused our independent auditor, in its audit opinion for the fiscal year ended March 31, 2022, to express substantial
doubt about the Company’s ability to continue as a going concern.
The Company’s operations have been financed
primarily by advances and loans from related parties and proceeds from sales of shares. Nevertheless, there can be no assurance that we
would be able to raise the additional funding needed to support our continuing operations, implement our business plans or cover unanticipated
costs.
Since we are an early stage company and have not
generated significant revenues and have experienced recurring losses, an investment in our shares is highly risky and could result in
a complete loss of your investment if we are unsuccessful in implementing our business plans and achieving profitable operations.
Based upon current plans, we expect to incur operating losses in future
periods as we incur significant expenses associated with the effort of expanding our business. Further, we cannot guarantee that we will
be successful in realizing sufficient revenues or in achieving or sustaining positive cash flows at any time in the future. Any such failure
could result in the possible closure of our business or force us to seek additional financing through loans or additional sales of our
equity securities to continue business operations, which could dilute the value of any shares you purchase.
COVID-19 has adversely impacted our
business and may further impact our business, financial results and liquidity for an unknown period of time.
The COVID-19 pandemic has led government
and other authorities to impose measures intended to control its spread, including restrictions on freedom of movement, gatherings of
large numbers of people, and temporary closure of company operations. The COVID-19 pandemic has led to significant disruptions
in our distribution operations and supply chains.
In response to COVID-19, we have taken steps
to reduce operating costs and improve efficiency, including furloughing of our employees. Such steps, and further changes we may make
in the future to reduce our costs, may negatively impact our ability to attract and retain employees. If this were to occur, we may experience
operational challenges that result in a negative impact on our customer services and ultimately, loss of market share, which could limit
our ability to grow and expand our business.
In addition to the disruption to many aspects of our business operations,
the COVID-19 pandemic has adversely impacted overall economic conditions and customer demand. We believe the COVID-19 pandemic
could continue to impact customer demand for our products and services and customer spending levels. Recently, there has been an
increasing number of COVID-19 cases, including cases involving the COVID-19 Delta and Omicron variants, in multiple cities in China. The
Chinese local authorities have reinstated certain measures to keep COVID-19 in check, including compulsory quarantine arrangements, travel
restrictions and stay-at-home orders. The reinstatement of these restrictions in early 2022 have adversely affected our operations by,
for example, making it more difficult to conduct our sales and marketing and promotional efforts. The COVID-19 global pandemic has resulted
in, and may intensify, global economic distress, and the duration and extent of the impact of COVID-19 outbreak is highly uncertain at
this time.
We are unable to predict the extent to which the
pandemic and related impacts will continue to adversely impact our business operations, financial performance, results of operations,
financial position and the achievement of our strategic objectives.
We have recently started a software development
business, and we may not be successful in this business.
The purpose of Tianci Wanguan is to promote the
use of blockchain technology in sales, specifically the development of tracing systems for agricultural products, the development of a
blockchain-based shopping mall for agricultural products, and related improvements to the agricultural industry. Our new software development
business may not be successful. Even if we achieve profitability in the future, we may not be able to sustain profitability in subsequent
periods.
Our marketing efforts will not be successful
if we are unable to develop a broad awareness of our brand.
Our business is now primarily focused on the marketing
and distribution of selenium-enriched rice paddy and other foodstuffs through our Yuxinqi subsidiary. Food distribution in China is a
highly competitive business, with many very large participants in the market. Our plan to increase participation in the market depends
on our ability to market our brand as a source for selenium-enriched products. By identifying our brand with the growing market for selenium-enriched
foodstuffs, we hope that growth will increase with the value of our brand. If this plan fails to be realized, it will be difficult for
us to distinguish Yuxinqi from the many small food distributors who operate with modest profitability, which may prevent our shareholders
from realizing value from their investment in the Company.
Some residents of China have recently begun
to use supplements to offset selenium deficiency in their diets. We cannot predict the extent to which they may come to prefer supplements
as a remedy for selenium deficiencies rather than selenium-enhanced food products.
Selenium deficiency has been a problem in eastern
China for centuries, and the relationship of selenium deficiencies to Keshan Disease has long been known. Until recently, efforts to alleviate
selenium deficiencies have been limited to changes in diet and the introduction of selenium-rich foods, where available. The use of selenium
supplements is relatively recent. The use of selenium supplements does offer certain advantages, however, selenium supplements, if purchased
from a reliable vendor, provide an assured quantity of selenium, whereas the selenium quantity in a specific item of grocery food is untested.
Selenium supplements may be more cost-effective than selenium-enhanced foods, depending on the development of the market for each. For
these and other reasons, the growth of the market for selenium supplements may be an obstacle to the growth of the market for selenium-enhanced
foods.
Product liability claims could materially
impact operating results and profitability.
Excessive ingestion of selenium can have serious
harmful effects on an individual. While our technicians will use their best efforts to achieve an optimal selenium content in our products,
many factors determine the selenium levels in a crop. Our technicians may be unable to determine when a crop contains an excess amount
of selenium. Moreover, even if our technicians are successful in optimizing the selenium value in our products, consumers who suffer symptoms
of selenium poisoning may focus their blame on our products. In either such situation, we may be subject to lawsuits for damages. Such
lawsuits could drain our financial resources, particularly as we do not presently carry any product liability insurance or business interruption
insurance. Lawsuits by customers may also distract the time and attention of our management. In addition, a product liability claim, regardless
of merit or eventual outcome, could result in damage to our reputation, decreased demand for our products, product recalls and loss of
revenue.
We do not presently maintain fire, theft,
product liability or any other property insurance, which leaves us with exposure in the event of loss or damage to our properties or claims
filed against us.
We do not maintain fire, theft, product liability
or other insurance of any kind. We bear the economic risk with respect to loss of or damage or destruction to our property and to the
interruption of our business, as well as liability to third parties for damage or destruction to them or their property that may be caused
by our personnel or products. Such liability could be substantial and the occurrence of such loss or liability may have a material adverse
effect on our business, financial condition and prospects.
We may not be able to effectively control
and manage our planned growth.
We have limited operational, administrative and
financial resources, which may be inadequate to sustain the growth we want to achieve. If our business and markets grow and develop, it
will be necessary for us to finance and manage expansion accordingly. In addition, we may face challenges in managing our expanding product
and service offerings, and in integrating any businesses we acquire with our own. Such growth would place increased demands on our existing
management, employees and facilities. Our failure to meet these demands could interrupt or adversely affect our operations and cause administrative
inefficiencies. Additionally, failure to execute our planned growth strategy could have a material adverse effect on our business, financial
condition and results of operation.
As a smaller marketing company with reporting
obligations, we may be at a competitive disadvantage to other food distribution companies. The food distribution industry has low barriers
to entry.
Because the food distribution market is competitive,
is driven in large part by costs, and consists mostly of private companies that do not have public reporting obligations, our reporting
obligations may put us at a competitive disadvantage. The food distribution industry has low barriers to entry, and is populated by a
number of giant companies as well as multitudes of modest to small companies. In addition, we will face additional expenses that a private
food distribution company does not have, such as PCAOB auditor fees, Edgar filing fees and legal fees related to our SEC reporting obligations.
Other non-public food distribution companies do not incur these costs. We are at a competitive disadvantage to our competitors because
of this.
Risks Relating to our Management
The loss of the services of any of our officers
or our failure to timely identify and retain competent personnel could negatively impact our ability to develop our products and sales.
The development of our business will continue
to place a significant strain on our limited personnel, management, and other resources. Our future success depends upon the continued
services of our executive officers, Shen Zhenai, our President, Chairman of the Board and Director, Xun Jianjun, our Chief Executive Officer
and Director, Wang Qiu, our Chief Financial Officer, as well as the continued involvement of Hao Shuping, our Director who brought together
the elements of our business. They are developing our business, which will depend on our ability to identify and retain competent employees
with the skills required to execute our business objectives. The loss of the services of any of our officers or our failure to timely
identify and retain competent personnel could negatively impact our ability to develop our products and sales, which could adversely affect
our financial results and impair our growth.
If we are unable to hire, retain or motivate
qualified personnel, consultants, independent contractors, and advisors, we may not be able to grow effectively.
Our performance will be largely dependent on the
talents and efforts of highly skilled individuals. Our future success depends on our continuing ability to identify, hire, develop, motivate
and retain highly qualified personnel for all areas of our organization. Competition for such qualified employees is intense. If we do
not succeed in attracting competent personnel or in retaining or motivating them, we may be unable to grow effectively. In addition, our
future success depends largely on our ability to retain key consultants and advisors. We cannot assure that any skilled individuals will
agree to become an employee, consultant, or independent contractor of Organic Agricultural Company Limited. Our inability to retain their
services could negatively impact our business and our ability to execute our business strategy.
Our internal controls over financial reporting
may not be effective and our independent registered public accounting firm may not be able to certify as to their effectiveness, which
could have a significant and adverse effect on our business and reputation.
As a newly public reporting company, we will be
in a continuing process of developing, establishing, and maintaining internal controls and procedures that will allow our management to
report on, and our independent registered public accounting firm to attest to, our internal controls over financial reporting if and when
required to do so under Section 404 of the Sarbanes-Oxley Act of 2002. Although our independent registered public accounting firm is not
required to attest to the effectiveness of our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley
Act until the date we are no longer an emerging growth company, our management will be required to report on our internal controls over
financial reporting under Section 404. If we fail to achieve and maintain the adequacy of our internal controls, we would not be able
to conclude on an ongoing basis that we have effective internal controls over financial reporting in accordance with Section 404. At such
time, our independent registered public accounting firm may issue a report that is adverse in the event it is not satisfied with the level
at which our controls are documented, designed or operating. Moreover, our testing, or the subsequent testing by our independent registered
public accounting firm, that must be performed may reveal other material weaknesses or that the material weaknesses noted have not been
fully remediated. If we do not remediate the material weaknesses noted, or if other material weaknesses are identified or we are not able
to comply with the requirements of Section 404 in a timely manner, our reported financial results could be materially misstated or could
subsequently require restatement, we could receive an adverse opinion regarding our internal controls over financial reporting from our
independent registered public accounting firm and we could be subject to investigations or sanctions by regulatory authorities, which
would require additional financial and management resources.
Our lack of an independent audit committee
and audit committee financial expert at this time may hinder our board of directors’ effectiveness in monitoring the Company’s
compliance with its disclosure and accounting obligations. Until we establish such committee, we will be unable to obtain a listing on
a national securities exchange.
Although our common stock is not listed on any
national securities exchange, for purposes of independence we use the definition of independence applied by NASDAQ. Currently, we have
no independent audit committee. Our board of directors functions as our audit committee and is comprised of four directors. An independent
audit committee would play a crucial role in the corporate governance process, assessing our Company’s processes relating to our
risks and control environment, overseeing financial reporting, and evaluating internal and independent audit processes. The lack of an
independent audit committee may deprive the Company of management’s independent judgment. We may, however, have difficulty attracting
and retaining independent directors with the requisite qualifications. If we are unable to attract and retain qualified, independent directors,
the management of our business could be compromised. An independent audit committee is required for listing on any national securities
exchange. Therefore, until such time as we meet the audit committee independence requirements of a national securities exchange, we will
be ineligible for listing on any national securities exchange.
Our board of directors acts as our compensation
committee, which presents the risk that compensation and benefits paid to those executive officers who are board members and other officers
may not be commensurate with our financial performance.
A compensation committee consisting of independent
directors is a safeguard against self-dealing by company executives. Our board of directors, which has no independent members, acts as
the compensation committee for the Company and determines the compensation and benefits of our executive officers, administers our employee
stock and benefit plans, and reviews policies relating to the compensation and benefits of our employees. Our lack of an independent compensation
committee presents the risk that an executive officer on the board may have influence over his or her personal compensation and benefit
levels that may not be commensurate with our financial performance or the market place.
Limitations on director and officer liability
and indemnification of our Company’s officers and directors by us may discourage stockholders from bringing a lawsuit against an
officer or director.
Our Company’s certificate of incorporation
and bylaws provide, with certain exceptions as required by governing state law, that a director or officer shall not be personally liable
to us or our stockholders for breach of fiduciary duty as a director or officer, except for acts or omissions which involve intentional
misconduct, fraud or knowing violation of law, or unlawful payments of dividends. These provisions may discourage stockholders from bringing
a lawsuit against a director or officer for breach of fiduciary duty and may reduce the likelihood of derivative litigation by stockholders
on the Company’s behalf against a director or officer.
Our management has limited experience managing
a public company.
At the present time, none of our management has
experience in managing a public company. This may hinder our ability to establish effective controls and systems and comply with all applicable
requirements associated with being a public company. If compliance problems result, these problems could have a material adverse effect
on our business, financial condition or results of operations. As a public company, we will incur significant legal, accounting and other
expenses that we did not incur as a private company. In addition, the Sarbanes-Oxley Act of 2002 and the Dodd-Frank Act of 2010, as well
as rules subsequently implemented by the SEC, have imposed various new requirements on public companies, including requiring changes in
corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to our new compliance
requirements. Moreover, these requirements will increase our legal, accounting and financial compliance costs and will make some activities
more time-consuming and costly. For example, we expect it will be difficult and expensive for us to obtain director and officer liability
insurance. These requirements could also make it more difficult for us to attract and retain independent and qualified persons to serve
on our board of directors, our board committees or as executive officers.
We may have difficulty establishing adequate
management, legal and financial controls in the PRC.
The PRC historically has not adopted a western
style of management and financial reporting concepts and practices, as in modern banking, computer and other control systems. We may have
difficulty in hiring and retaining a sufficient number of qualified employees to work in the PRC. As a result of these factors, we may
experience difficulty in establishing management, legal and financial controls, collecting financial data and preparing financial statements,
books of account and corporate records and instituting business practices that meet western standards. Therefore, we may, in turn, experience
difficulties and additional costs in implementing and maintaining adequate internal controls as required under Section 404 of the Sarbanes
Oxley Act of 2002.
Risks Related to Regulation
The recent joint statement by the SEC and
PCAOB and the Holding Foreign Companies Accountable Act all call for additional and more stringent criteria to be applied to emerging
market companies upon assessing the qualification of their auditors, especially the non-U.S. auditors who are not inspected by the PCAOB.
Furthermore, on June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, which, if enacted, would
amend the HFCA Act and require the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchanges if its auditor
is not subject to PCAOB inspections for two consecutive years instead of three. These developments could add uncertainties to holding
and investing in shares of our common stock.
On April 21, 2020, the SEC Chairman Jay Clayton
and PCAOB Chairman William D. Duhnke III, along with other senior SEC staff, released a joint statement highlighting the risks associated
with investing in companies based in or have substantial operations in emerging markets including China. The joint statement emphasized
the risks associated with lack of access for the PCAOB to inspect auditors and audit work papers in China and higher risks of fraud in
emerging markets.
On May 18, 2020, Nasdaq filed three proposals
with the SEC to (i) apply minimum offering size requirement for companies primarily operating in a “Restrictive Market”, (ii)
adopt a new requirement relating to the qualification of management or board of directors for Restrictive Market companies, and (iii)
apply additional and more stringent criteria to an applicant or listed company based on the qualifications of the company’s auditors.
On May 20, 2020, the U.S. Senate passed the Holding
Foreign Companies Accountable Act requiring a foreign company to certify it is not owned or controlled by a foreign government if the
PCAOB is unable to audit specified reports because the company uses a foreign auditor not subject to PCAOB inspection. If the PCAOB is
unable to inspect the company’s auditors for three consecutive years, the issuer’s securities are prohibited to trade on a
national securities exchange or in the over-the-counter trading market in the U.S. On December 2, 2020, the U.S. House of Representatives
approved the Holding Foreign Companies Accountable Act. On December 18, 2020, the Holding Foreign Companies Accountable Act was signed
into law.
On March 24, 2021, the SEC announced that it had
adopted interim final amendments to implement congressionally mandated submission and disclosure requirements of the Act. The interim
final amendments will apply to registrants that the SEC identifies as having filed an annual report on Forms 10-K, 20-F, 40-F or N-CSR
with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB has determined
it is unable to inspect or investigate completely because of a position taken by an authority in that jurisdiction. The SEC will implement
a process for identifying such a registrant and any such identified registrant will be required to submit documentation to the SEC establishing
that it is not owned or controlled by a governmental entity in that foreign jurisdiction, and will also require disclosure in the registrant’s
annual report regarding the audit arrangements of, and governmental influence on, such a registrant.
On June 22, 2021, the U.S. Senate passed the Accelerating
Holding Foreign Companies Accountable Act, which, if enacted, would amend the HFCA Act and require the SEC to prohibit an issuer’s
securities from trading on any U.S. stock exchanges if its auditor is not subject to PCAOB inspections for two consecutive years instead
of three. This would reduce the time period before our securities may be prohibited from trading or delisted from three years to two years.
On September 22, 2021, the PCAOB adopted a final
rule implementing the HFCAA, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCAA, whether
the Board is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because
of a position taken by one or more authorities in that jurisdiction.
On December 16, 2021, PCAOB issued a report on
its determination that the PCAOB is unable to inspect or investigate completely PCAOB-registered public accounting firms headquartered
in mainland China and in Hong Kong, a Special Administrative Region of the PRC, because of positions taken by PRC authorities in those
jurisdictions. The PCAOB made these determinations pursuant to PCAOB Rule 6100, which provides a framework for how the PCAOB fulfills
its responsibilities under the Holding Foreign Companies Accountable Act (the “HFCAA”). If the PCAOB is unable to inspect
or investigate completely a registered public accounting firm headquartered in mainland China or Hong Kong because of a position taken
by one or more authorities in mainland China or Hong Kong, investors are deprived of the benefits of such PCAOB inspections, which could
cause investors to lose confidence in audit procedures and the quality of financial statements. In addition, under the HFCAA, a company’s
securities may be prohibited from trading on the U.S. stock exchanges or in the over-the-counter trading market in the U.S. if its auditor
is not inspected by the PCAOB, and this ultimately could result in a company’s common stock being delisted.
The audit report included in this annual report
on Form 10-K for the year ended March 31, 2022, was issued by Wei, Wei & Co., LLP, a U.S.-based accounting firm that is registered
with the PCAOB and can be inspected by the PCAOB. Our auditor is headquartered in New York and is subject to inspection by the PCAOB on
a regular basis with the last inspection in 2020. We have no intention of dismissing Wei, Wei & Co., LLP in the future or of engaging
any auditor not based in the U.S. and not subject to regular inspection by the PCAOB. There is no guarantee, however, that any future
auditor engaged by the Company would remain subject to full PCAOB inspection during the entire term of our engagement.
However, the recent developments would add uncertainties
to holding and investing in our common stock and we cannot assure you whether regulatory authorities would apply additional and more stringent
criteria to us after considering the effectiveness of our auditor’s audit procedures and quality control procedures, adequacy of
personnel and training, or sufficiency of resources, geographic reach or experience as it relates to the audit of our financial statements.
It remains unclear what the SEC’s implementation process related to the June 2021 interim final amendments will entail or what further
actions the SEC or the PCAOB will take to address these issues and what impact those actions will have on U.S. companies that have significant
operations in the PRC and have securities listed on a U.S. stock exchange (including a national securities exchange or over-the-counter
stock market). In addition, the June 2021 interim final amendments and any additional actions, proceedings, or new rules resulting from
these efforts to increase U.S. regulatory access to audit information could create some uncertainty for investors, the market price of
our common stock could be adversely affected, and we could be delisted if we and our auditor are unable to meet the PCAOB inspection requirements
or being required to engage a new audit firm, which would require significant expense and management time.
Changes in the policies of the PRC government
could have an adverse effect on our business.
Policies of the PRC government can have significant
effects on the economic conditions in the PRC. Although the PRC government has been pursuing economic reform policies and transitioning
to a market-oriented economy, there is no assurance that the government will continue to pursue such policies or that such policies may
not be significantly altered, especially in the event of a change in leadership, social or political disruption, or other circumstances
affecting the PRC’s political, economic and social conditions. Our business could be adversely affected by changes in PRC government
policies, including but not limited to changes in policies relating to taxation, currency conversion, imports and exports, and ownership
of private enterprises.
PRC laws and regulations governing our current
business operations are sometimes vague and subject to interpretation, and any changes in PRC laws and regulations may have a material
and adverse effect on our business.
There are substantial uncertainties regarding
the interpretation, application and enforcement of PRC laws and regulations, including but not limited to the laws and regulations governing
our business. These laws and regulations are sometimes vague and are subject to future changes, and their official interpretation and
enforcement by the various branches of the PRC government may involve substantial uncertainty. The PRC legal system is based in part on
governmental policies and internal rules some of which are not published on a timely basis or at all. New laws, regulations, rules and
policies that affect existing and proposed future businesses may also be applied retroactively. We cannot predict with certainty what
effect existing or new PRC laws or regulations may have on our business. In addition, there is less published guidance regarding PRC laws
as compared to laws in the United States, and prior rulings and interpretations of PRC laws may not necessarily carry the same precedential
value as in the United States.
Governmental control of currency conversion
may affect the value of your investment.
The People’s Republic of China (PRC) government
imposes controls on the convertibility of Renminbi (RMB) into foreign currencies and, in certain cases, the remittance of currency out
of the PRC. We receive substantially all of our revenues in RMB, which is currently not a freely convertible currency. Shortages in the
availability of foreign currency may restrict our ability to remit sufficient foreign currency to pay dividends, or otherwise satisfy
foreign currency denominated obligations. Under existing PRC foreign exchange regulations, payments of current account items, including
profit distributions, interest payments and expenditures from the transaction, can be made in foreign currencies without prior approval
from the PRC State Administration of Foreign Exchange by complying with certain procedural requirements. However, approval from appropriate
governmental authorities is required where RMB is to be converted into foreign currency and remitted out of the PRC to pay capital expenses
such as the repayment of bank loans denominated in foreign currencies.
The PRC government also may at its discretion
restrict access in the future to foreign currencies for current account transactions. If the foreign exchange control system prevents
us from obtaining sufficient foreign currency to satisfy our currency demands, we may not be able to pay certain of our expenses as they
come due.
The fluctuation of RMB may materially and
adversely affect your investment.
The value of the RMB against the U.S. dollar and
other currencies may fluctuate and is affected by, among other things, changes in the PRC’s political and economic conditions. As
we rely entirely on revenues earned in the PRC, any significant revaluation of RMB may materially and adversely affect our cash flows,
revenues and financial condition. For example, to the extent that we need to convert U.S. dollars we receive from an offering of our securities
into RMB for our operations, appreciation of the RMB against the U.S. dollar could have a material adverse effect on our business, financial
condition and results of operations. Conversely, if we decide to convert our RMB into U.S. dollars for the purpose of making dividend
payments on our common stock or for other business purposes and the U.S. dollar appreciates against the RMB, the U.S. dollar equivalent
of the RMB we convert would be reduced. In addition, the depreciation of significant U.S. dollar denominated assets could result in a
charge to our income statement and a reduction in the value of these assets.
Because our principal assets are located
outside of the United States and because all of our directors and all our officers reside outside of the United States, it may be difficult
for you to use the United States Federal securities laws to enforce your rights against us and our officers or to enforce judgments of
United States courts against us or them in the PRC.
All of our present officers and directors reside
outside of the United States. In addition, our operating subsidiaries, Tianci Liangtian, Yuxinqi and Tianci Wanguan, are located in the
PRC and substantially all of their assets are located outside of the United States. It may therefore be difficult for investors in the
United States to enforce their legal rights based on the civil liability provisions of the United States Federal securities laws against
us in the courts of either the United States or the PRC and, even if civil judgments are obtained in courts of the United States, to enforce
such judgments in PRC courts. Further, it is unclear if extradition treaties now in effect between the United States and the PRC would
permit effective enforcement against us or our officers and directors of criminal penalties, under the United States Federal securities
laws or otherwise.
Risks Relating to Our Common Stock
We are an emerging growth company and, as
a result of the reduced disclosure and governance requirements applicable to emerging growth companies, our common stock may be less attractive
to investors.
We are an emerging growth company, as defined
in the JOBS Act, and we are eligible to take advantage of certain exemptions from various reporting requirements applicable to other public
companies. The exemptions available to emerging growth companies include the right to present only two years of audited financial statements
in our registration statements and annual reports, an exemption from the auditor attestation requirement of Section 404(b) of the Sarbanes-Oxley
Act relating to internal controls, reduced disclosure about executive compensation arrangements, and no requirement to seek non-binding
advisory votes on executive compensation or golden parachute arrangements. Some of these exemptions are also available to us as a smaller
reporting company (i.e. a company with less than $250 million of its voting equity held by non-affiliates). We have elected to adopt these
reduced disclosure requirements. We cannot predict if investors will find our common stock less attractive as a result of our taking advantage
of these exemptions. If some investors find our common stock less attractive as a result of our choices, there may be a less active trading
market for our common stock and our stock price may be more volatile.
Pursuant to Section 107(b) of the JOBS Act, we
have elected to use the extended transition period for complying with new or revised accounting standards under Section 102(b)(2) of The
JOBS Act. This election allows us to delay the adoption of new or revised accounting standards that have different effective dates for
public and private companies until those standards apply to private companies. As a result, our financial statements may not be comparable
to companies that comply with public company effective dates. This election is irrevocable.
Because the worldwide market value of our common
stock held by non-affiliates, or public float, was below $250 million on the last day of our second quarter, we are also a “smaller
reporting company” as defined under the Exchange Act. Some of the foregoing reduced disclosure and other requirements are also available
to us because we are a smaller reporting company and may continue to be available to us even after we are no longer an emerging growth
company under the JOBS Act but remain a smaller reporting company under the Exchange Act. As a smaller reporting company, we are not required
to:
| ● | have
an auditor report on our internal control over financial reporting pursuant to Section 404(b) of the Sarbanes-Oxley Act; |
| ● | present
more than two years of audited financial statements in our registration statements and annual reports on Form 10-K; or |
| ● | present
any selected financial data in such registration statements and annual reports filings made by the Company. |
Because we will be subject to “penny
stock” rules, the level of trading activity in our stock may be reduced.
Until we are able to secure a listing for our
common stock on a national securities exchange, it is likely that our common stock will be classified as a “penny stock”.
Penny stocks generally are equity securities with a price of less than $5.00 (other than securities registered on some national securities
exchanges). Broker-dealer practices in connection with transactions in “penny stocks” are regulated by penny stock rules adopted
by the Securities and Exchange Commission. The penny stock rules require a broker-dealer, prior to a transaction in a penny stock not
otherwise exempt from the rules, to deliver a standardized risk disclosure document that provides information about penny stocks and the
nature and level of risks in the penny stock market. The broker-dealer also must provide the customer with current bid and offer quotations
for the penny stock, the compensation of the broker-dealer and its salesperson in the transaction, and, if the broker-dealer is the sole
market maker, the broker-dealer must disclose this fact and the broker-dealer’s presumed control over the market, and monthly account
statements showing the market value of each penny stock held in the customer’s account. In addition, broker-dealers who sell these
securities to persons other than established customers and “accredited investors” must make a special written determination
that the penny stock is a suitable investment for the purchaser and receive the purchaser’s written agreement to the transaction.
Consequently, these requirements may have the effect of reducing the level of trading activity, if any, in the secondary market for a
security subject to the penny stock rules. If a trading market does develop for our common stock, these regulations will likely be applicable,
and investors in our common stock may find it difficult to sell their shares.
FINRA sales practice requirements may limit
a stockholder’s ability to buy and sell our stock.
FINRA has adopted rules that require that in recommending
an investment to a customer, a broker-dealer must have reasonable grounds for believing that the investment is suitable for that customer.
Prior to recommending speculative low-priced securities to their non-institutional customers, broker-dealers must make reasonable efforts
to obtain information about the customer’s financial status, tax status, investment objectives and other information. Under interpretations
of these rules, FINRA believes that there is a high probability that speculative low-priced securities will not be suitable for at least
some customers. FINRA requirements make it more difficult for broker-dealers to recommend that their customers buy our common stock, which
may have the effect of reducing the level of trading activity in our common stock. As a result, fewer broker-dealers may be willing to
make a market in our common stock, reducing a stockholder’s ability to resell shares of our common stock.
Shareholders do not have pre-emptive rights,
which will cause them to experience dilution if we issue additional securities.
In the future, we may issue or sell additional
shares of our authorized but previously unissued shares of common stock, preferred stock, or common stock warrants on such terms and conditions
as our Board of Directors, in its sole discretion, may determine without consent of our shareholders. Our shareholders do not have pre-emptive
rights to acquire additional shares should we in the future issue or sell additional securities. Thus, we are not required to offer any
existing shareholder the right to purchase his or her pro rata portion of any future issuance of securities and, therefore, upon the issuance
of any additional securities by us hereafter, our shareholders will not be able to maintain their then existing pro rata ownership in
our outstanding shares of common stock, preferred stock, or common stock warrants without additional purchases of securities at the price
then set internally by us or the market.
We are unlikely to pay cash dividends in
the foreseeable future.
We currently intend to retain any future earnings
for use in the operation and expansion of our business. We do not expect to pay any cash dividends in the foreseeable future but will
review this policy as circumstances dictate. Should we decide in the future to do so, as a holding company, our ability to pay dividends
and meet other obligations depends upon the receipt of dividends or other payments from our operating subsidiaries. Our operating subsidiaries,
from time to time, may be subject to restrictions on their ability to make distributions to us, including as a result of restrictions
on the conversion of local currency into U.S. dollars or other hard currency and other regulatory restrictions. The PRC government imposes
controls on the convertibility of the RMB into foreign currencies and, in certain cases, the remittance of currency out of China. In addition,
each of our subsidiaries in China is required to set aside at least 10% of its after-tax profits each year, if any, to fund a statutory
reserve until such reserve reaches 50% of its registered capital. Each of such entity in China is also required to further set aside a
portion of its after-tax profits to fund the employee welfare fund, although the amount to be set aside, if any, is determined at the
discretion of its board of directors. Although the statutory reserves can be used, among other ways, to increase the registered capital
and eliminate future losses in excess of retained earnings of the respective companies, the reserve funds are not distributable as cash
dividends except in the event of liquidation.
If we are considered a PRC tax resident enterprise
for tax purposes, any dividends we pay to our overseas shareholders may be regarded as China-sourced income and as a result may be subject
to PRC withholding tax at a rate of up to 10.0%. Certain payments from our PRC subsidiaries are subject to PRC taxes.
Pursuant to the Arrangement between Mainland China
and the Hong Kong Special Administrative Region for the Avoidance of Double Taxation and Tax Evasion on Income, or the Double Tax Avoidance
Arrangement, the 10% withholding tax rate may be lowered to 5% if a Hong Kong resident enterprise owns no less than 25% of a PRC entity.
However, the 5% withholding tax rate does not automatically apply and certain requirements must be satisfied, including, without limitation,
that (a) the Hong Kong entity must be the beneficial owner of the relevant dividends; and (b) the Hong Kong entity must directly hold
no less than 25% share ownership in the PRC entity during the 12 consecutive months preceding its receipt of the dividends. In current
practice, a Hong Kong entity must obtain a tax resident certificate from the Hong Kong tax authority to apply for the 5% lower PRC withholding
tax rate. As the Hong Kong tax authority will issue such a tax resident certificate on a case-by-case basis, we cannot assure you that
we will be able to obtain the tax resident certificate from the relevant Hong Kong tax authority and enjoy the preferential withholding
tax rate of 5% under the Double Taxation Arrangement with respect to dividends to be paid by our PRC subsidiary to its immediate holding
company. As of the date of filing of this report, our PRC subsidiary currently does not have plan to declare and pay dividends and we
have not applied for the tax resident certificate from the relevant Hong Kong tax authority. The Company intends to apply for the tax
resident certificate when our PRC subsidiary plans to declare and pay dividends. When our PRC subsidiary plans to declare and pay dividends
and when we intend to apply for the tax resident certificate from the relevant Hong Kong tax authority, we plan to inform the investors
through SEC filings, such as a current report on Form 8-K, prior to such actions.